HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lesley Burgess Selected Research

Cholesterol

5/2014A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lesley Burgess Research Topics

Disease

2Heart Failure
01/2023 - 02/2015
1COVID-19
01/2022
1Left Ventricular Dysfunction
02/2015
1Cardiovascular Diseases (Cardiovascular Disease)
01/2015
1Nasopharyngitis
01/2015
1Hyperlipidemias (Hyperlipidemia)
05/2014

Drug/Important Bio-Agent (IBA)

2evolocumabIBA
01/2015 - 05/2014
1omecamtiv mecarbilIBA
01/2023
1molnupiravirIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2015
1Angiotensin Receptors (Angiotensin II Receptor)IBA
02/2015
1Neprilysin (Neutral Endopeptidase)IBA
02/2015
1sacubitril and valsartan sodium hydrate drug combinationIBA
02/2015
1candesartanIBA
02/2015
1LDL CholesterolIBA
01/2015
1CholesterolIBA
05/2014

Therapy/Procedure

1Investigational Therapies (Experimental Therapy)
02/2015